COVID-19 Impact on Global Recombinant Vaccines Market By Patient Type (Pediatric and Adult Patients); By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines and Toxoid Vaccines) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
COVID-19 Impact on Global Recombinant Vaccines Market By Patient Type (Pediatric and Adult Patients); By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines and Toxoid Vaccines) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
- 1. Executive Summary
- 2. Recombinant Vaccines Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3. Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4. Average Pricing Analysis
- 5. Market Dynamics
- 5.1. Growth Drivers
- 5.2. Restraints
- 5.3. Opportunity
- 5.4. Trends
- 6. Correlation & Regression Analysis
- 6.1. Correlation Matrix
- 6.2. Regression Matrix
- 7. Recent Development, Policies & Regulatory Landscape
- 8. Risk Analysis
- 8.1. Demand Risk Analysis
- 8.2. Supply Risk Analysis
- 9. Recombinant Vaccines Market Analysis
- 9.1. Porters Five Forces
- 9.1.1. Threat of New Entrants
- 9.1.2. Bargaining Power of Suppliers
- 9.1.3. Threat of Substitutes
- 9.1.4. Rivalry
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10. Recombinant Vaccines Market
- 10.1. Market Size & forecast, 2019A-2030F
- 10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11. Recombinant Vaccines Market: Market Segmentation
- 11.1. By Regions
- 11.1.1. North America:(U.S. and Canada)
- 11.1.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
- 11.1.2.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
- 11.1.3.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
- 11.1.4.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 11.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
- 11.1.5.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12. Recombinant Vaccines Market: Market Segmentation
- 12.1. By technology: Market Share (2020-2030F)
- 12.1.1. conjugate vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.2. inactivated and subunit vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.3. live attenuated vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.4. recombinant vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.1.5. toxoid vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2. By patient type : Market Share (2020-2030F)
- 12.2.1. pediatric, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 12.2.2. adult patients, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- 13. Company Profile
- 13.1. Johnson and Johnson
- 13.1.1. Company Overview
- 13.1.2. Company Total Revenue (Financials)
- 13.1.3. Market Potential
- 13.1.4. Global Presence
- 13.1.5. Key Performance Indicators
- 13.1.6. SWOT Analysis
- 13.1.7. Product Launch
- 13.2. Abiomed
- 13.3. Emergent Bio Solutions, Inc.
- 13.4. GlaxoSmithKline
- 13.5. Sanofi Pasteur SA
- 13.6. Serum Institute of India Pvt. Ltd
- 13.7. Mitsubishi Tanabe Pharma Corporation
- 13.8. Daiichi Sankyo
- 13.9. Pfizer, Inc.
- 13.10. Other prominent players
- Consultant Recommendation
- **The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook